PANW up +2.00% percent right now. $PANW High is at 109.78

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
PANW up +2.00% percent right now. $PANW High is at 109.78 and the Low 105.90 with current volume of 945,647.

Recent News posted below.

PANW Palo Alto Networks Inc Recent Headline News

FireEye vs. Palo Alto: Which Is the Better Stock?
Brian Nichols, The Motley Fool - Motley Fool - Mon Nov 10, 8:29AM CST
It wasn't too long ago that  FireEye 's   stock was fast approaching a price of $100 per share. The stock now trades around $30. Meanwhile, cybersecurity peer Palo Alto Networks   is trading near its all-time...
HD: 97.44 (-0.21), FEYE: 32.10 (+1.48), JPM: 61.70 (+0.23), TGT: 65.23 (+1.06), VZ: 51.01 (+0.15), AAPL: 108.98 (-0.03), PANW: 109.43 (+2.41), MS: 35.63 (-0.03)

Cybersecurity firm IDs new Apple-targeting malware
By TOM MURPHY - AP - Thu Nov 06, 8:50AM CST
Palo Alto Networks has discovered a new form of malware that may have affected hundreds of thousands of Apple mobile device users, largely in China.
PANW: 109.43 (+2.41), AAPL: 108.98 (-0.03)

Palo Alto Networks (PANW) Stock Higher Today After Discovering Malware in Apple (AAPL) Systems
at The Street - Thu Nov 06, 8:19AM CST
Shares of Palo Alto Networks (PANW) are up in pre-market trading after discovering a new family of malware that can infect Apple's (AAPL) desktop and mobile operating systems.
PANW: 109.43 (+2.41)

Palo Alto discovers unprecedented iOS and OS X malware
M2 - Thu Nov 06, 5:54AM CST
Palo Alto Networks (NYSE: PANW) said it has discovered a new family of Apple OS X and iOS malware exhibiting characteristics unseen in any previously documented threats targeting Apple platforms.
PANW: 109.43 (+2.41)

'Fast Money' Recap: Tesla's a Buy Despite the 4Q Guidance
at The Street - Thu Nov 06, 4:00AM CST
The trading panel discussed earnings reports from Tesla, Whole Foods Market and Qualcomm.
WFM: 47.52 (+0.71), TSLA: 241.52 (+1.32), FEYE: 32.10 (+1.48), MDT: 68.48 (+0.38), OIH: 44.74 (-0.26), QCOM: 69.47 (+0.21), SO: 47.52 (+0.39), PANW: 109.43 (+2.41)

Palo Alto Networks Reveals Discovery of Unprecedented iOS and OS X Malware
PR Newswire - Wed Nov 05, 4:45PM CST
Palo Alto Networks® (NYSE: PANW), the leader in enterprise security, today announced discovery of a new family of Apple OS X and iOS malware exhibiting characteristics unseen in any previously documented threats targeting Apple platforms. This new family, dubbed WireLurker, marks a new era in malware across Apple's desktop and mobile platforms, representing a potential threat to businesses, governments and Apple customers worldwide.
PANW: 109.43 (+2.41)

Jim Cramer Says to Avoid FireEye, TripAdvisor After Earnings
at The Street - Wed Nov 05, 10:00AM CST
TheStreet's Jim Cramer pointed to FireEye's poor outlook and TripAdvisor's "triple-whammy" of negativity as reasons to avoid the two stocks.
FEYE: 32.08 (+1.46), TRIP: 73.07 (-0.58), PANW: 109.43 (+2.41), PCLN: 1,107.41 (+12.80)

Stock Market Today: Stocks Lose Momentum Following Republican Wins
at The Street - Wed Nov 05, 9:58AM CST
U.S. stocks turn mixed on Wednesday after the GOP seizes control of the Senate.
WFM: 47.52 (+0.71), TSLA: 241.52 (+1.32), FEYE: 32.08 (+1.46), MDLZ: 37.62 (-0.14), TRIP: 73.07 (-0.58), PANW: 109.43 (+2.41), PCLN: 1,107.41 (+12.80), TWX: 77.01 (+0.01), FOXA: 34.40 (-0.21), FTNT: 27.06 (-0.04), CBS: 51.92 (+0.61)

Stock Market Today: Futures Signal a Strong Start After GOP's Senate Win
at The Street - Wed Nov 05, 7:30AM CST
U.S. stocks are poised for a strong start Wednesday after the GOP seizes control of the Senate.
WFM: 47.52 (+0.71), TSLA: 241.52 (+1.32), FEYE: 32.08 (+1.46), FOXA: 34.40 (-0.21), PANW: 109.43 (+2.41), FTNT: 27.06 (-0.04), TWX: 77.01 (+0.01), CBS: 51.92 (+0.61)

Druva Hires Sunil Wadhwa as VP Customer Success & Operations
PRWeb - Wed Nov 05, 7:06AM CST
Druva, provider of data protection and governance solutions for the edge of the enterprise, today announced the appointment of 20-year technology customer success specialist Sunil Wadhwa to serve in the role of VP of Customer Success & Operations. His appointment coincides with ongoing global growth of Druva's inSync endpoint data protection and governance platform as well as the introduction of its new Phoenix cloud-first backup solution for servers.
PANW: 109.43 (+2.41)

Finjan Holdings' Subsidiary Files New Patent Infringement Lawsuit Against Palo Alto Networks
PR Newswire - Wed Nov 05, 7:00AM CST
Finjan Holdings, Inc. (NASDAQ: FNJN), a technology company committed to advancing innovation through the licensing of its intellectual property (IP), today announced that its subsidiary, Finjan, Inc. (Finjan) has filed a patent infringement lawsuit against Palo Alto Networks, Inc. (NYSE: PANW) (Palo Alto Networks), alleging infringement of Finjan patents relating to endpoint, web, and network security technologies.
FNJN: 2.84 (-0.16), PANW: 109.43 (+2.41)

FIREEYE
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
FIREEYE (FEYE) lost 51 cents a share, better than Q3 views for a loss of 55 cents and a Q3 '13 loss of $1.21. But while sales rose 167.8% to $114.2 mil, they missed views for $116 mil. The cybersecurity firm also gave weak guidance. Shares fell 20%....
FEYE: 32.09 (+1.47), CYBR: 34.38 (+1.67), PANW: 109.43 (+2.41)

Stocks End Mixed; Jazz Pharma Rises After Hours
at Investor's Business Daily - Tue Nov 04, 4:11PM CST
Stocks closed mixed, as earnings reports shook some stocks after the bell. The Nasdaq and S&P 500 dropped 0.3%, and the Dow Jones industrial average gained 0.1%. Volume was higher on the NYSE and lower on the Nasdaq, according to preliminary figures....
TSLA: 241.48 (+1.28), ACT: 246.22 (+0.31), FEYE: 32.09 (+1.47), AWAY: 29.45 (+0.24), CYBR: 34.38 (+1.67), JAZZ: 172.54 (+1.74), TRIP: 73.07 (-0.58), PANW: 109.43 (+2.41), ATHM: 44.12 (+0.49)

Palo Alto Networks to Announce Fiscal First Quarter 2015 Financial Results on Monday, November 24, 2014
PR Newswire - Mon Nov 03, 7:30AM CST
Palo Alto Networks, Inc. (NYSE: PANW) today announced that it will release its financial results for its first quarter of fiscal year 2015 ended October 31, 2014 after U.S. markets close on Monday, November 24, 2014. Palo Alto Networks will host a conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results.
PANW: 109.43 (+2.41)

Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500
at Investor's Business Daily - Mon Oct 27, 2:00PM CDT
Stocks were slightly lower in late trading Monday. But a couple of the major indexes continued to fight near the neutral zone. The Dow Jones industrial average and the Nasdaq were off by 0.1% each. The S&P 500 fell 0.3%, hurt by energy stocks. Energy...
MU: 32.82 (-0.19), GPRO: 76.28 (-2.78), AMGN: 162.07 (+1.82), MPWR: 44.62 (-0.07), CGNX: 40.75 (+0.13), BWLD: 158.56 (+1.05), PANW: 109.43 (+2.41), LCI: 51.20 (+1.03), CPHD: 52.39 (+0.70), TRUE: 16.51 (+0.09), TWTR: 40.06 (-0.25)

3 Growth Stocks Hitting 52 Week Highs
Leo Sun, The Motley Fool - Motley Fool - Mon Oct 27, 11:19AM CDT
With the stock market constantly hovering near all-time highs, investors might be wondering if popular growth stocks near 52-week highs still have any room left to run. Let's take a look at three stocks that have defied fundamental gravity over the...
VIPS: 24.48 (+1.14), FB: 74.96 (-0.64), FTNT: 27.06 (-0.04), PANW: 109.43 (+2.41), CHKP: 74.92 (+0.25)

Indexes Pare Losses As Airlines Soar
at Investor's Business Daily - Mon Oct 27, 10:58AM CDT
Stocks continued to pare losses in late-morning trading, briefly lifting the Dow into positive territory. The S&P 500 was down 0.4% and the Nasdaq dipped 0.2% while the Dow lost 0.1%. Volume was tracking higher on the NYSE and lighter on the Nasdaq...
LCI: 51.20 (+1.03), SAVE: 78.64 (+1.33), HA: 18.38 (+0.01), JBLU: 12.93 (+0.37), ALK: 55.97 (+0.83), PANW: 109.43 (+2.41), UAL: 54.77 (+0.59)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Oct 24, 6:54PM CDT
Earnings will take center stage and Cramer will be watching Merck, Twitter and Facebook, among many others.
BDSI: 16.15 (+0.65), GPRO: 76.28 (-2.78), MCK: 200.60 (+1.28), AXP: 92.32 (+0.06), PNRA: 168.29 (unch), FB: 74.96 (-0.64), DECK: 88.69 (-1.28), XOM: 96.37 (-0.22), BWLD: 158.56 (+1.05), SO: 47.51 (+0.38), PANW: 109.43 (+2.41), PAA: 53.51 (-0.77), WLP: 125.44 (+1.29), SBUX: 77.64 (-0.15), PH: 128.07 (-0.43), GILD: 107.37 (+0.92), MRK: 59.00 (-0.34), DD: 70.44 (+0.03), PAY: 37.02 (+0.46), TWTR: 40.06 (-0.25), CVX: 117.66 (-1.14), AAPL: 109.00 (-0.01), HLSS: 18.97 (-0.07)

Insider Trading Alert - PANW, AAPL And SNDK Traded By Insiders
at The Street - Fri Oct 24, 9:15AM CDT
Stocks with insider trader activity include PANW, AAPL and SNDK
AAPL: 109.00 (-0.01), PANW: 109.43 (+2.41), SNDK: 93.36 (+0.53)

Check Point Software Technologies Ltd's Earnings Were Stronger Than You Think
Lee Samaha, The Motley Fool - Motley Fool - Thu Oct 23, 4:11PM CDT
The information-technology network security sector is unusual in the sense that its leading companies offer markedly different maturity levels . If FireEye and Palto Alto Networks are the new kids on the...
PANW: 109.43 (+2.41), FTNT: 27.06 (-0.04), CHKP: 74.92 (+0.25)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading